Report Overview

The U.S. Head and neck cancer drugs market size stood at USD 0.5 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period

Cancers of the head and neck are categorized depending on the location. These areas include oral cavity, pharynx, larynx, paranasal sinuses & nasal cavity, and salivary glands. Increase in consumption of alcohol and tobacco is a major cause of head and neck cancer. An estimated 75% of head and neck cancers is caused due to consumption of alcohol and tobacco. Increase in the number of head and neck cancer patients across the world is anticipated to drive demand for therapeutics



Market Drivers

Rise in scientific and technological advancements in R&D and manufacturing processes is expected to increase the efficiency of drug development. However, a significant number of clinical trials fail to meet desired results. This acts as a major restraint of the U.S. head and neck cancer market and in turn limits the entry of new players. For instance, in 2017, phase 3 trial designed to evaluate pembrolizumab for the treatment of patients with recurrent or metastatic head and neck squamous cell carcinoma failed to meet its pre-specified primary endpoint of overall survival. It is noted that the rising prevalence of head and neck cancers is the key factor driving the head and neck cancer market

Various other factors such as growing geriatric population, huge research funding in oncology, unmet medical needs, rising competition among market players, improving regulatory framework, aging population, and increasing government assistance are continuously contributing to the growth of the U.S. head and neck cancer market

Despite these drivers, there are some issues associated with the head and neck cancer market. The high cost associated with treatment approach, side effects of available treatment options, lack of healthcare coverage, and poor healthcare system in low- and middle-income countries may hamper the growth of the market